Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1992;1(3):167–169. doi: 10.1155/S0962935192000255

Involvement of serotonin and eicosanoids in the rat paw oedema response to the essential oil of Pilocarpus spicatus

J C R Silva 1, V S N Rao 1,✉
PMCID: PMC2365341  PMID: 18475456

Abstract

Subplantar injection of Pilocarpus spicatus essential oil (PSEO), induced rat hindpaw oedema in a dose-dependent manner. The time course study revealed that when compared to carrageenan-induced oedema, the oedema response to PSEO was greater at 1 h post-injection, and thereafter remained relatively constant until 5 h post-injection. By 24 h, it was still at almost the 50% level. This effect of PSEO was characterized using several inhibitors of oedema formation. Pretreatment with the H1-receptor antagonist chlorpheniramine did not affect this response, while a significant reduction of paw oedema was achieved with the serotonin antagonist methysergide, but only 1 h and 2 h after injection of PSEO. The oedemagenic activity of PSEO was also suppressed by pretreating the rats with the eicosanoid synthesis inhibitors, phenylbutazone, EP 10161 and dexamethasone. This last drug showed the greatest potency. These findings suggested a probable injury to dermal mast cells and liberation of arachidonate metabolites and eicosanoids at the late phase of oedema induced by PSEO.

Full Text

The Full Text of this article is available as a PDF (267.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. De Clerck F., Loots W., Somers Y., Van Gorp L., Verheyen A., Wouters L. Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blocker. Arch Int Pharmacodyn Ther. 1985 Mar;274(1):4–23. [PubMed] [Google Scholar]
  2. Goodwin J. S. Mechanism of action of nonsteroidal anti-inflammatory agents. Am J Med. 1984 Jul 13;77(1A):57–64. doi: 10.1016/s0002-9343(84)80020-0. [DOI] [PubMed] [Google Scholar]
  3. Lombardino J. G., Otterness I. G., Wiseman E. H. Acidic antiinflammatory agents--correlations of some physical, pharmacological and clinical data. Arzneimittelforschung. 1975 Oct;25(10):1629–1635. [PubMed] [Google Scholar]
  4. Otterness I. G., Gans D. J. Nonsteroidal anti-inflammatory drugs: an analysis of the relationship between laboratory animal and clinical doses, including species scaling. J Pharm Sci. 1988 Sep;77(9):790–795. doi: 10.1002/jps.2600770915. [DOI] [PubMed] [Google Scholar]
  5. PARRATT J. R., WEST G. B. Inhibition by various substances of oedema formation in the bind-paw of the rat induced by 5-hydroxytryptamine, histamine, dextran, egg-white and compound 48/80. Br J Pharmacol Chemother. 1958 Mar;13(1):65–70. doi: 10.1111/j.1476-5381.1958.tb00192.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Tsurufuji S., Sugio K., Takemasa F. The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature. 1979 Aug 2;280(5721):408–410. doi: 10.1038/280408a0. [DOI] [PubMed] [Google Scholar]
  7. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  8. Vinegar R., Truax J. F., Selph J. L., Johnston P. R., Venable A. L., McKenzie K. K. Pathway to carrageenan-induced inflammation in the hind limb of the rat. Fed Proc. 1987 Jan;46(1):118–126. [PubMed] [Google Scholar]
  9. Zipser R. D., Laffi G. Prostaglandins, thromboxanes and leukotrienes in clinical medicine. West J Med. 1985 Oct;143(4):485–497. [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES